Lv1
30 积分 2023-10-09 加入
Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
2小时前
待确认
Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management
3小时前
已完结
Spatial regulation of glucose and lipid metabolism by hepatic insulin signaling
14天前
已完结
HR-pQCT reveals marked trabecular and cortical structural deficits in women with pregnancy and lactation associated osteoporosis (PLO)
1个月前
已完结
Evaluation of quality and bone microarchitecture alterations in osteopetrosis patients: assessed by HR-pQCT
1个月前
已完结
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes
1个月前
已完结
Denosumab for osteoporosis in older adults in long‐term care: A randomized trial
2个月前
已完结
Current status and future trends of the global burden of MASLD
2个月前
已完结
Frailty and risk of metabolic dysfunction–associated steatotic liver disease and other chronic liver diseases
2个月前
已完结
Glycemic variability and the risk of nonalcoholic fatty liver disease : A nationwide population-based cohort study
2个月前
已完结
皖公网安备34019202002308
